Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2018Radiotherapy and OncologyOpen Access

Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SLShao-Bo LiangSun Yat-sen UniversityNZNing ZhangGuangzhou University of Chinese MedicineDCDan-Ming Chen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liang et al. (2018) studied this question.

synapsesocial.com/papers/6aacce96c7e070df51ecc472https://doi.org/10.1016/j.radonc.2018.10.010
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy2017 · 51 citations
  2. 2New Guidelines to Evaluate the Response to Treatment in Solid Tumors2000 · 15,764 citations
  3. 3Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival2001 · 141 citations
  4. 4Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx1990 · 39 citations